Form 4: Lemaitre Vascular President Exercises Stock Options

Lemaitre Vascular's President and Director, David B. Roberts, exercised stock options to acquire 2,679 shares of common stock on February 5, 2026.

Summary

• David B. Roberts, President and Director of Lemaitre Vascular Inc. (LMAT), acquired 2,679 shares of common stock through the exercise of stock options.
• On February 5, 2026, Roberts exercised options for 2,672 shares at an exercise price of $37.29 per share.
• On the same date, Roberts also exercised options for 7 shares at an exercise price of $48.60 per share.
• These options were fully vested and exercisable, with original exercisable dates of December 2, 2020, and December 11, 2021, respectively.
• Following these transactions, Roberts directly beneficially owns 24,930 shares of Lemaitre Vascular common stock.
• The transactions were made pursuant to a Rule 10b5-1(c) plan.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a moderately positive signal. While an option exercise is often pre-planned, the insider's decision to acquire shares rather than let options expire suggests continued confidence in the company's value.

Positives

• An insider (President and Director) is increasing direct beneficial ownership in the company by exercising options, aligning their interests with shareholders.
• The exercise of options indicates a belief in the long-term value of the company, as the insider is choosing to convert options into shares rather than letting them expire.
• The options were exercised at prices ($37.29 and $48.60) which are likely below the current market price, indicating a profitable transaction for the insider.

Negatives

• The transaction was conducted under a Rule 10b5-1(c) plan, which means it was pre-scheduled and may not reflect new discretionary buying sentiment based on recent non-public information.

Industry Context

StockSavvy.ai notes that insider transactions, particularly option exercises, are common in the medical device sector as part of executive compensation packages. While this specific transaction is pre-planned, it reflects the ongoing compensation structure for key executives at Lemaitre Vascular, a company focused on vascular devices.

Stakeholder Impact

• Shareholders: The increase in insider ownership, even through option exercise, can be viewed positively as it aligns management's interests with shareholders.
• Employees: This filing primarily concerns executive compensation and does not directly impact the broader employee base.

Key Dates

Recommendation

While the exercise of options by a key executive is generally a positive indicator of confidence, the fact that it was a pre-planned transaction under Rule 10b5-1(c) mitigates its immediate signal strength as a discretionary buy. It confirms the executive's continued stake in the company but doesn't necessarily suggest new, urgent positive developments. Therefore, a "hold" recommendation is appropriate, acknowledging the positive alignment without implying a strong new catalyst for price appreciation based solely on this filing.

Keywords

Lemaitre Vascular, LMAT, David B. Roberts, Insider Trading, Stock Options, Option Exercise, Beneficial Ownership, SEC Form 4, Medical Devices, Vascular Devices